Search
Search
Journalism from the heart of crises
  1. Home
  2. East Africa
  3. Kenya
  • News

GSK to boost HIV/AIDS healthcare rollout

    JOHANNESBURG
    Multinational drug manufacturer GlaxoSmithKline (GSK) has announced a multimillion-dollar programme to improve HIV/AIDS treatment at 60 facilities in Kenya. The firm's CEO, Jean Pierre Garnier, said the US $1.8 million initiative aimed to advance healthcare delivery and strengthen access to support services in the country's most deeply affected communities. In a statement Garnier said, "Together we will bring hope and improved treatment to thousands of people affected by the pandemic in Kenya." He noted that the three-year project, funded by his firm's 'Positive Action' community support programme, had the potential to be rolled out in other African countries as well. According to the National Empowerment Network of People Living with HIV/AIDS in Kenya, there are an estimated 2.2 million people living with the HI virus.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Get the day’s top headlines in your inbox every morning

    Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

    DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

    Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

    It’s the perfect way to start your day.

    Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join